Ischemic Compression After Dry Needling of a Latent Myofascial Trigger Point Reduces Postneedling Soreness Intensity and Duration

Aitor Martín-Pintado-Zugasti; Daniel Pecos-Martin; Ángel Luis Rodríguez-Fernández; Isabel María Alguacil-Diego; Alicia Portillo-Aceituno; Tomás Gallego-Izquierdo; Josue Fernandez-Carnero

doi:10.1016/j.pmrj.2015.03.021

Ischemic Compression After Dry Needling of a Latent Myofascial Trigger Point Reduces Postneedling Soreness Intensity and Duration

PM R. 2015 Oct;7(10):1026-1034. doi: 10.1016/j.pmrj.2015.03.021. Epub 2015 Mar 31.

Authors

Aitor Martín-Pintado-Zugasti¹, Daniel Pecos-Martin², Ángel Luis Rodríguez-Fernández³, Isabel María Alguacil-Diego⁴, Alicia Portillo-Aceituno⁴, Tomás Gallego-Izquierdo², Josue Fernandez-Carnero⁵

Affiliations

¹ Department of Physical Therapy, CEU-San Pablo University, Carretera Boadilla del Monte, Km 5,300, Urbanización Montepríncipe, 28668 Boadilla del Monte, Madrid, Spain.
² Physiotherapy Department, School of Physiotherapy, Alcalá de Henares University, Alcalá de Henares, Madrid, Spain.
³ Department of Physical Therapy, Faculty of Medicine, CEU-San Pablo University, Madrid, Spain.
⁴ Department of Physical Therapy, Occupational Therapy, Rehabilitation and Physical Medicine, Rey Juan Carlos University, Madrid, Spain.
⁵ Department of Physical Therapy, Occupational Therapy, Rehabilitation and Physical Medicine, Rey Juan Carlos University, Madrid, Spain; Hospital La Paz Institute for Health Research, IdiPAZ, Madrid, Spain.

PMID: 25836591
DOI: 10.1016/j.pmrj.2015.03.021

Abstract

Objective: To investigate the effect of ischemic compression (IC) versus placebo and control on reducing postneedling soreness of 1 latent myofascial trigger point and on improving cervical range of motion (CROM) in asymptomatic subjects.

Design: A randomized, double-blind, placebo-controlled trial with 72-hour follow-up.

Setting: A university community.

Participants: Asymptomatic volunteers (N = 90: 40 men and 50 women) aged 18 to 39 years (mean ± standard deviation [SD]: 22 ± 3 years).

Intervention: All subjects received a dry needling application over the upper trapezius muscle. Participants were then randomly divided into 3 groups: a treatment group who received IC over the needled trapezius muscle, a placebo group who received sham IC, and a control group who did not receive any treatment after needling.

Main outcome measures: Visual analog scale (VAS; during needling, at posttreatment and 6, 12, 24, 48, and 72 hours) and CROM (at preneedling, postneedling, and 24 and 72 hours).

Results: Subjects in the IC group showed significantly lower postneedling soreness than the placebo and the control group subjects immediately after treatment (mean ± standard deviation [SD]: IC, 20.1 ± 4.8; placebo, 36.7 ± 4.8; control, 34.8 ± 3.6) and at 48 hours (mean ± SD: IC, 0.6 ± 1; placebo, 4.8 ± 1; control, 3.8 ± 0.7). In addition, subjects in the dry needling+IC group showed significantly lower postneedling soreness duration (P = .026). All subjects significantly improved CROM in contralateral lateroflexion and both homolateral and contralateral rotations, but only the improvements found in the IC group reached the minimal detectable change.

Conclusions: IC can potentially be added immediately after dry needling of myofascial trigger point in the upper trapezius muscle because it has the effect of reducing postneedling soreness intensity and duration. The combination of dry needling and IC seems to improve CROM in homolateral and contralateral cervical rotation movements.

Trial registration: ClinicalTrials.gov NCT02169700.

Publication types

Randomized Controlled Trial

MeSH terms

Adolescent
Adult
Constriction
Double-Blind Method
Female
Humans
Male
Myofascial Pain Syndromes / rehabilitation*
Needles
Physical Stimulation
Physical Therapy Modalities*
Range of Motion, Articular
Superficial Back Muscles
Trigger Points*
Young Adult

Associated data

ClinicalTrials.gov/NCT02169700